Charles River Laboratories International (CRL) Depreciation and Depletion (2011 - 2025)

Charles River Laboratories International's Depreciation and Depletion history runs 15 years deep, the most recent figure standing at $45.1 million for Q4 2025.

• In Q4 2025, Depreciation and Depletion fell 6.82% year-over-year to $45.1 million; the TTM figure through Dec 2025 stood at $177.6 million (down 6.62% YoY), while the FY2025 annual figure was $177.6 million, down 6.62% from the prior year.
• Depreciation and Depletion was $45.1 million for Q4 2025 at Charles River Laboratories International, up from $44.8 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $155.6 million in Q4 2022 to a low of $559000.0 in Q1 2022.
• Historically, Depreciation and Depletion has averaged $42.1 million across 5 years, with a median of $44.4 million in 2023.
• Biggest YoY gain for Depreciation and Depletion was 7878.53% in 2023; the steepest drop was 70.12% in 2023.
• A 5-year view of Depreciation and Depletion shows it stood at $138.6 million in 2021, then advanced by 12.28% to $155.6 million in 2022, then slumped by 70.12% to $46.5 million in 2023, then rose by 4.09% to $48.4 million in 2024, then fell by 6.82% to $45.1 million in 2025.
• The last three Depreciation and Depletion figures came in at $45.1 million (Q4 2025), $44.8 million (Q3 2025), and $44.3 million (Q2 2025), per Business Quant data.